Nath Bio-Genes (India) Limited NATHBIOGEN NSEINFRA
Company Overview
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising cabbage, French beans, chili, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, coriander, sweet pepper, green peas, pumpkin, and tinda. It also provides plant protection products under the Win-chi-Win, WINPro WinGoli, and WINall brands; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX brand names. The company was founded in 1979 and is based in Mumbai, India.
Why Investors Should Care
Revenue has grown at a 13.9% CAGR over the past five years.
Trades at a P/E of 7.1, below the sector median of 20.9.
Carries low leverage with a debt-to-equity ratio of 0.20.
Recent Developments
- Mar 2026 Revenue of ₹445.10 Cr (+22.0% YoY); net profit ₹41.63 Cr.
- Trailing 12 Months Year-on-year growth — revenue +15.8%, earnings -13.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.9%, profit CAGR 5.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.88% |
| 1 Year: | 15.80% |
Compounded Profit Growth
| 5 Years: | 5.94% |
| 1 Year: | -13.30% |
Stock Price Performance
| 1 Year: | -24.73% |
| 6 Months: | -23.04% |
| 3 Months: | -18.35% |
| 1 Month: | -14.12% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)30.90 · Neutral
P/E of 7.07 is below the sector median of 20.95 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.9% over 5 years.
CONS
- Trading 32.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NATHBIOGEN Nath Bio-Genes (India) Limited NSEINFRA | 130.37 | 7.07 | ₹247.76 Cr | 1.47% | 8.86% | 6.12% | 13.88% | 5.94% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 10,958.00 | 37.77 | ₹3.22 L Cr | 2.25% | 11.84% | 10.66% | 11.92% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,220.00 | 12.04 | ₹2.98 L Cr | 0.58% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,284.80 | 45.45 | ₹2.19 L Cr | 1.19% | 24.41% | 20.24% | 1.10% | 1.75% |
| 5 | HINDZINC Hindustan Zinc Limited NSEINFRA | 518.00 | 12.82 | ₹2.19 L Cr | 2.07% | 61.97% | 61.13% | 5.61% | 9.58% |
| 6 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 172.33 | 19.47 | ₹2.15 L Cr | 2.33% | 11.32% | 10.56% | -1.59% | 7.21% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 885.60 | 12.01 | ₹1.97 L Cr | 0.56% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 2,894.40 | 34.52 | ₹1.96 L Cr | 0.35% | 3.98% | 4.80% | 14.30% | -10.06% |
| 9 | SOLARINDS Solar Industries India Limited NSEINFRA | 19,010.00 | 86.39 | ₹1.72 L Cr | 0.06% | 29.51% | 26.72% | 12.39% | 30.36% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.99 Cr | 235.28 Cr | 22.57 Cr | 31.74 Cr | 43.04 Cr | 243.88 Cr | 32.19 Cr | 36.87 Cr | 51.97 Cr | 283.70 Cr | 43.85 Cr | 65.96 Cr | 51.59 Cr | 328.40 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 17.68 Cr | 139.82 Cr | 17.11 Cr | 28.78 Cr | 15.80 Cr | 164.80 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 34.29 Cr | 143.88 Cr | 26.74 Cr | 37.18 Cr | 35.79 Cr | 163.60 Cr |
| Operating Expenses | 41.06 Cr | 198.26 Cr | 17.58 Cr | 26.09 Cr | 39.11 Cr | 207.34 Cr | 27.38 Cr | 28.83 Cr | 35.22 Cr | 115.57 Cr | 21.63 Cr | 34.58 Cr | 32.34 Cr | 129.46 Cr |
| Operating Income | 2.94 Cr | 36.26 Cr | 4.23 Cr | 4.89 Cr | 2.95 Cr | 35.71 Cr | 3.98 Cr | 7.21 Cr | -92.80 L | 28.31 Cr | 5.12 Cr | 2.60 Cr | 3.45 Cr | 34.15 Cr |
| EBITDA | 3.93 Cr | 37.02 Cr | 4.99 Cr | 5.65 Cr | 3.93 Cr | 36.54 Cr | 4.81 Cr | 8.04 Cr | 4.28 Cr | 33.11 Cr | 10.10 Cr | 8.00 Cr | 8.11 Cr | 38.25 Cr |
| Interest Expense | 1.53 Cr | 2.76 Cr | 2.44 Cr | 2.84 Cr | 1.07 Cr | 2.24 Cr | 2.98 Cr | 3.90 Cr | 1.37 Cr | 3.20 Cr | 3.66 Cr | 4.54 Cr | 4.59 Cr | 4.26 Cr |
| Pretax Income | 1.67 Cr | 33.62 Cr | 1.85 Cr | 4.59 Cr | 3.24 Cr | 33.60 Cr | 1.08 Cr | 3.79 Cr | 1.57 Cr | 28.94 Cr | 5.46 Cr | 2.48 Cr | 2.49 Cr | 32.98 Cr |
| Tax Provision | 23.00 L | 21.85 L | 35.00 L | 77.02 L | 62.01 L | 24.86 L | -3.00 L | 1.14 Cr | 62.73 L | 65.97 L | 64.11 L | 87.28 L | 2.50 Cr | 72.09 L |
| Net Income | 1.43 Cr | 33.41 Cr | 1.50 Cr | 3.82 Cr | 2.62 Cr | 33.35 Cr | 1.11 Cr | 2.65 Cr | 1.48 Cr | 28.28 Cr | 2.75 Cr | 1.60 Cr | -89,000 | 32.26 Cr |
| Diluted EPS | 0.76 | 17.59 | 0.79 | 2.02 | 1.38 | 17.55 | 0.58 | 1.39 | 0.42 | 14.88 | 1.40 | 0.84 | -0.79 | 16.98 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 97.00 Cr | 109.00 Cr | - | 301.36 Cr | 332.62 Cr | 364.91 Cr | 445.10 Cr |
| Cost of Revenue | - | - | - | 114.61 Cr | 113.57 Cr | 135.55 Cr | 201.50 Cr |
| Gross Profit | - | - | - | 186.75 Cr | 219.05 Cr | 229.36 Cr | 243.60 Cr |
| Operating Expenses | 82.00 Cr | 89.00 Cr | - | 140.72 Cr | 172.22 Cr | 183.38 Cr | 195.12 Cr |
| Operating Income | 10.00 Cr | 15.00 Cr | - | 46.04 Cr | 46.84 Cr | 45.98 Cr | 48.47 Cr |
| EBITDA | 15.00 Cr | 20.00 Cr | - | 51.76 Cr | 56.72 Cr | 54.34 Cr | 66.26 Cr |
| Interest Expense | 2.00 Cr | 4.00 Cr | - | 9.57 Cr | 8.63 Cr | 10.48 Cr | 15.99 Cr |
| Pretax Income | 9.00 Cr | 12.00 Cr | - | 36.16 Cr | 41.56 Cr | 40.04 Cr | 46.30 Cr |
| Tax Provision | -9.00 L | 48.00 L | - | 1.15 Cr | 1.95 Cr | 1.98 Cr | 4.67 Cr |
| Net Income | 9.00 Cr | 12.00 Cr | - | 35.01 Cr | 39.62 Cr | 38.60 Cr | 41.63 Cr |
| Diluted EPS | 5.75 | 7.34 | - | 18.43 | 20.85 | 20.14 | 20.98 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | 120.00 Cr | 158.00 Cr | - | 792.80 Cr | 880.23 Cr | 1,026.21 Cr | 1,097.42 Cr |
| Current Assets | - | - | - | 519.83 Cr | 571.66 Cr | 690.01 Cr | 778.86 Cr |
| Cash & Equivalents | - | - | - | 37.99 Cr | 77.13 Cr | 88.53 Cr | 76.00 Cr |
| Inventory | - | - | - | 207.85 Cr | 230.31 Cr | 338.02 Cr | 450.55 Cr |
| Receivables | - | - | - | 97.31 Cr | 94.31 Cr | 88.90 Cr | 85.41 Cr |
| Total Liabilities | - | - | - | 219.62 Cr | 270.31 Cr | 381.82 Cr | 416.96 Cr |
| Current Liabilities | - | - | - | 216.43 Cr | 262.45 Cr | 365.30 Cr | 394.70 Cr |
| Long Term Debt | - | - | - | 40.32 L | 4.87 Cr | 12.98 Cr | 17.32 Cr |
| Total Debt | 11.00 Cr | 19.00 Cr | - | 105.21 Cr | 110.35 Cr | 122.50 Cr | 138.50 Cr |
| Total Equity | 46.00 Cr | 57.00 Cr | - | 573.17 Cr | 609.92 Cr | 644.39 Cr | 680.46 Cr |
| Shares Outstanding | - | - | - | 1.90 Cr | 1.90 Cr | 1.90 Cr | 1.90 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | 38.37 Cr | 74.59 Cr | 17.58 Cr | -12.57 Cr |
| Investing Cash Flow | - | - | - | -2.88 Cr | -27.40 Cr | -3.96 Cr | 3.46 Cr |
| Financing Cash Flow | - | - | - | -1.67 Cr | -7.78 Cr | -2.13 Cr | -3.79 Cr |
| Capital Expenditure | - | - | - | -2.55 Cr | -26.78 Cr | -7.92 Cr | -3.01 Cr |
| Free Cash Flow | - | - | - | 35.82 Cr | 47.82 Cr | 9.66 Cr | -15.58 Cr |
| Net Change in Cash | - | - | - | 33.81 Cr | 39.41 Cr | 11.49 Cr | -12.90 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 62.0% | 65.9% | 62.9% | 54.7% |
| Operating Margin % | 10.3% | 13.8% | - | 15.3% | 14.1% | 12.6% | 10.9% |
| Net Margin % | 9.3% | 11.0% | - | 11.6% | 11.9% | 10.6% | 9.4% |
| ROE % | 19.6% | 21.1% | - | 6.1% | 6.5% | 6.0% | 6.1% |
| ROCE % | - | - | - | 8.0% | 7.6% | 7.0% | 6.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NATHBIOGEN
Nath Bio-Genes (NATHBIOGEN.NS) Slips 1.43% to ₹135.71 as Seed Counter Tests Near-Term Support - Earnings Sentiment - https://www.siam.in/
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQVjlXSEllYnYzd3BqS25pNlVBbHI5RkdOdTRYVndEN3VDeEI3WDN6Smk5ZmpzZFN6Und1aDJsT1FqRTZQLTdUS3plaXBiUVE4aXh4dS1BR2lzYjl2elBQTFBYenNaZ0tSdlcwSDNSYmxRaU94Vk5hR1IxLUdKXzFobGhUZmpya0kwdmdnQV…
Nath Bio-Genes (NSE:NATHBIOGEN): Has It Filed the Q2 FY27 Depository Compliance Certificate? - Kalkine India
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxORXlfb1l2cTNmM0s4REhUQjVKcUd1dUp6dlhJWnZPZk40enlsbVBzVmo4VFlrUXoxQm5IYjh6ejZNSElQWkRHdFFRS1VlVThZVXdpYklDdGJjTVNLTmdvU1hOaTdod0RSWVUyWWVqRkFiMUtPdUp3SzFaNzFaLVJTVjdDOHJuN1hkV2RjRT…
NATHBIOGEN Stock Price and Chart — NSE:NATHBIOGEN - TradingView
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1ucnV0SFAtamhTbEFWajl3WXJDNTVuRlNITGVSSlFEZ3ZIaG40QWJ6eUZWZmRVZUtieFpPR0FoMVpyZlhOUllrQjNvd1RfYWc2cFlBSXRHblhyRjhrdkwxZA?oc=5" target="_blank">NATHBIOGEN Stock Price and Chart — NS…
Nath Bio-Genes (NATHBIOGEN.NS) Eases 0.76% to ₹147.01, Holding Above ₹139.66 Support - Investment Factor - siam.in
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQX3VwV0VXc3FiaG1GVHpReEFKenE1a2xya0VPaF9JeDJQeXN1cmFrc1hyd1UwVVJOem8tWlB6X25hTlJvWnpNUTExUzNQcl9hQkRyc3liRmJUeS1Kc1lGekhNa3RPSGNIOTNkdC1ZVnhiN1NxdXpyRXN6MWpNZVZ3V25Kc2RXZkczd0UwRl…
Why Is Nath Bio-Genes India Share Price Falling Key Reasons 2026 - Univest
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE1aZ3B6NTBza1FoSzVTV05FOG5sN2VIc0pmUUJXOGxXVUtwNEdpLS1ZeEs1RFpoVFNPbTlwd0lxOVNnc0JsOVRPQzgxTW1jUFZvNlVDbjdKM1E4Zjhzd1d1RGFTNEJaTVROYUI2OU16SFh0ekVMY0hJVG4tdzg?oc=5" target="_blank">…
Nath Bio-Genes (NATHBIOGEN.NS) Slips 2.25% to ₹148.38, Holding Mid-Range Between Key Levels - Arms Index - https://www.siam.in/
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTzZPU0RmNEh2WDNmRFNwZ3hLYldQSWUyai16a0FPeGthNlNzVTUzbUpSLTYxS2lTYUpDV095T3pwWGlXVFcyNlAwM25MLV9Wd1YySlluSExfQmZ5ZkFWaVYyR0FIMDRCYzE2cm1QS2o5U3FrbzhiSlhGeENhOWtnZDZlNTBNd0dVQU9lZW…
NATHBIOGEN — Frequently Asked Questions
What is the current share price of Nath Bio-Genes (India) Limited (NATHBIOGEN)?
As of 2026-10-24 04:55 IST, Nath Bio-Genes (India) Limited (NATHBIOGEN) trades at ₹130.37 on NSE. Its 52-week range is ₹127.33 to ₹193.44.
What is the market capitalisation of NATHBIOGEN?
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a market capitalisation of ₹247.76 Cr on NSE.
What is the P/E ratio of NATHBIOGEN?
NATHBIOGEN trades at a trailing price-to-earnings (P/E) ratio of 7.07. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 0.45.
Does NATHBIOGEN pay a dividend?
Nath Bio-Genes (India) Limited (NATHBIOGEN) currently offers a dividend yield of 1.47%.
What is the return on equity (ROE) of NATHBIOGEN?
NATHBIOGEN has a return on equity (ROE) of 6.12%. Its return on capital employed (ROCE) is 8.86%.
Is NATHBIOGEN a good stock to buy?
This page provides a data-driven analysis of Nath Bio-Genes (India) Limited (NATHBIOGEN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.